For more VICC news, visit their website »
Music will set the tone for Vanderbilt-Ingram Cancer Center’s annual Cancer Survivorship Celebration for patients, friends and families.
A novel PET imaging probe detects tumor cell death in vivo and could be useful for personalizing cancer medicine.
A genetic variant is associated with toxicity of the chemotherapy drug melphalan, and could guide individualized dosing for the medication.
A retired elementary school principal has become the first patient at Vanderbilt-Ingram Cancer Center to receive an investigational cancer therapy for the treatment of his neuroendocrine tumor.
Research led by Joan Garrett, Ph.D., research instructor in Hematology/Oncology, reveals a molecular mechanism that may explain why some forms of breast cancer become resistant to therapy.